Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort study
达拉非尼联合曲美替尼对比抗PD-1单药治疗BRAF V600突变型III期黑色素瘤根治术后辅助治疗:一项多中心回顾性队列研究
期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2024.102564
Bai, Xue; Shaheen, Ahmed; Grieco, Charlotte; d'Arienzo, Paolo D; Mina, Florentia; Czapla, Juliane A; Lawless, Aleigha R; Bongiovanni, Eleonora; Santaniello, Umberto; Zappi, Helena; Dulak, Dominika; Williamson, Andrew; Lee, Rebecca; Gupta, Avinash; Li, Caili; Si, Lu; Ubaldi, Martina; Yamazaki, Naoya; Ogata, Dai; Johnson, Rebecca; Park, Benjamin C; Jung, Seungyeon; Madonna, Gabriele; Hochherz, Juliane; Umeda, Yoshiyasu; Nakamura, Yasuhiro; Gebhardt, Christoffer; Festino, Lucia; Capone, Mariaelena; Ascierto, Paolo Antonio; Johnson, Douglas B; Lo, Serigne N; Long, Georgina V; Menzies, Alexander M; Namikawa, Kenjiro; Mandala, Mario; Guo, Jun; Lorigan, Paul; Najjar, Yana G; Haydon, Andrew; Quaglino, Pietro; Boland, Genevieve M; Sullivan, Ryan J; Furness, Andrew J S; Plummer, Ruth; Flaherty, Keith T